Back to results
US 2009/0156671 A1Published application
Deuterium-enriched oxybutynin
AssigneeProtia, LLC
InventorAnthony W. Czarnik
Life of this patent
Estimating the term…
Abstract
The present application describes deuterium-enriched oxybutynin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
Claims27
A method for treating overactive bladder comprising:
- administering, to a patient in need thereof, a therapeutically effective amount of a deuterium-enriched compound of formula I or a pharmaceutically acceptable salt thereof:
- wherein R1-R31 are independently selected from H and D;
- and the abundance of deuterium in R1-R31 is at least 3% provided that the compound is other than:
- (a) a compound where each of R22-R31 is D or
- (b) a compound where each of R20-R21 is D.
2 more elements
A method for treating overactive bladder comprising:
- administering, to a patient in need thereof, a therapeutically effective amount of a compound of formula I or a pharmaceutically acceptable salt thereof:
- wherein R1-R31 are independently selected from H and D;
- and the abundance of deuterium in R1-R31 is at least 3% provided that the compound is other than:
- (a) a compound where each of R22-R31 is D or
- (b) a compound where each of R20-R21 is D.
2 more elements
A method for treating overactive bladder comprising:
- administering, to a patient in need thereof, a therapeutically effective amount of a mixture of deuterium-enriched compounds of formula I or a pharmaceutically acceptable salt thereof:
- wherein R1-R31 are independently selected from H and D;
- and the abundance of deuterium in R1-R31 is at least 3% provided that the compound is other than:
- (a) a compound where each of R22-R31 is D or
- (b) a compound where each of R20-R21 is D.
2 more elements
Dependencies are inferred from the claim text.